(1R,2R)-(-)-N-(4-Toluenesulphonyl)-1,2-diphenylethylenediamine, 98.0%, 10g

2,4,6-Trimethoxyaniline, 97.0%, 5g

2-(3-Bromophenyl)-1,3-thiazole-4-carboxylic acid, 97.0%, 5g

4-(4-(Trifluoromethoxy)phenyl)piperidine hydrochloride, 95.0%, 100mg

2'-chloro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] hydrochloride, 95.0%, 250mg

Stand plates stable position, 150 mm, 300 mm, 1 Piece

(R)-2-Amino-2-(4-bromophenyl)acetic acid, 95+%, 5g

((4-(o-tolyloxy)phenyl)sulfonyl)leucine, 95.0%, 500mg

2-Pyridin-3-yl-thiazole-4-carboxylic acid, 95.0%, 1g

N-(4-Fluorophenyl)maleimide>98.0%(GC)200mg

3-(4-(Bromomethyl)phenyl)-5-methyl-1,2,4-oxadiazole, 95.0%, 250mg

Linoleic Acid>97.0%(GC)(T)5g

Methyl 1H-1,2,4-triazole-3-carboxylate, 88.0%, 500g